Franklin Resources (BEN) and Invesco (IVZ) are two of the most closely watched names in the traditional asset-management industry, yet they present investors with contrasting profiles. BEN is a turnaround story centered on a diversified global platform and a rebound in organic flows, while IVZ is a scale-driven ETF and index powerhouse with a stronger operating margin. For income-oriented investors, momentum traders, and those evaluating relative performance within the financials sector, this stock comparison highlights where the two firms stand on growth, sentiment, and market positioning after a period of broadly rising markets.
Franklin Resources, operating as Franklin Templeton, is a global investment manager spanning equities, fixed income, multi-asset, alternatives, and cash management. In recent quarters, the company has signaled a meaningful inflection: total AUM reached record territory around $1.8 trillion, supported by long-term net inflows across public and private markets. Management has emphasized positive flows across every asset class and region, with alternatives AUM climbing to a record and private-markets fundraising running ahead of full-year targets.
The firm's relative performance has been a bright spot. Over roughly the past six months, BEN shares have appreciated strongly while the broader finance and investment-management industry declined, reflecting improving sentiment as long-standing outflows at its Western Asset Management unit fade. An analyst upgrade in recent weeks highlighted "early signs of a turnaround," and the stock carries one of the more favorable research ratings among peers. A dividend yield above 4% has also attracted income-focused buyers, though the company's investment performance across certain funds remains a point of scrutiny.
Invesco is a global asset manager with a larger AUM base, recently around $2.5 trillion, weighted toward equities and a substantial passive/ETF franchise. Its signature QQQ product and a record ETF and index platform near $775 billion in AUM have driven much of its recent growth. The firm has now logged more than a dozen consecutive quarters of net long-term inflows, with notable strength in Europe, the Middle East, Africa, and Asia-Pacific.
Operationally, IVZ has expanded its adjusted operating margin to roughly 40%, among the highest in years, helped by expense discipline and the consolidation of its investment platforms. Management has also reduced net debt and retired a large portion of preferred stock, improving balance-sheet flexibility. That said, active fundamental equities and fixed income continue to experience net outflows, and the company's earnings per share (EPS) has occasionally come in modestly below consensus. Its dividend yield is lower than BEN's, and its shares have shown more choppiness in recent trading sessions.
Tickeron's Trending AI Robots page showcases a curated selection of the platform's hundreds of AI trading bots, which collectively trade thousands of different tickers. Because not every automated strategy suits every market regime, only the bots demonstrating the strongest, most consistent alignment with current conditions earn a place in this section. The featured robots span a wide range of trading styles, strategies, timeframes, performance statistics, and target tickers, allowing traders to compare approaches rather than settle for a one-size-fits-all signal. For those evaluating opportunities like the BEN and IVZ comparison, reviewing the Trending AI Robots can provide a data-driven perspective on how automated systems are currently positioning across the market.
While both companies earn the bulk of revenue from asset-based fees, their business models emphasize different growth engines. IVZ is more heavily weighted toward passive and ETF products, which scale efficiently and have delivered record inflows but also compress fee rates. BEN is more diversified across active strategies and is aggressively expanding into alternatives and private markets, which carry higher fees but introduce different execution and performance risks.
On momentum and market sentiment, the contrast is sharp. BEN has been a relative outperformer, benefiting from a turnaround narrative and fading outflows, while IVZ pairs robust top-line and margin gains with lingering active-fund outflows and occasional EPS shortfalls. From an income standpoint, BEN offers the higher yield. On profitability and scale, IVZ holds the edge in operating margin and total AUM. Risk profiles differ accordingly: IVZ faces fee-rate compression and mix-shift pressures, while BEN must demonstrate that its diversified platform can sustain organic growth and competitive investment performance over time.
On observable factors such as trend consistency, relative performance, and the durability of recent catalysts, the Tickeron AI framework currently leans toward BEN over IVZ. BEN's combination of record AUM, accelerating long-term inflows, fading legacy outflows, a higher dividend yield, and stronger recent price momentum against its peer group gives it a relatively more stable and favorable technical and fundamental setup. IVZ remains a higher-margin, larger-scale operator with impressive ETF growth, but its mix of active-fund outflows and periodic earnings misses introduces comparatively more unevenness. This assessment is probabilistic rather than definitive and reflects current market positioning rather than a guaranteed outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for BEN crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where BEN advanced for three days, in 200 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 128 of 218 cases where BEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The 10-day RSI Indicator for BEN moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 22 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 32 of 49 cases where BEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BEN as a result. In 64 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for BEN turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
BEN moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
BEN broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. BEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.460) is normal, around the industry mean (2.423). P/E Ratio (22.946) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.407) is also within normal values, averaging (1.318). Dividend Yield (0.039) settles around the average of (0.274) among similar stocks. P/S Ratio (1.814) is also within normal values, averaging (15.906).
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IVZ declined for three days, in 201 of 287 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 56 cases where IVZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 66%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In 58 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for IVZ turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 31 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
The Aroon Indicator for IVZ entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IVZ's RSI Indicator exited the oversold zone, 20 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
Following a +6.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in 227 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.200) is normal, around the industry mean (2.423). IVZ has a moderately low P/E Ratio (-40.418) as compared to the industry average of (8.341). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (1.318). Dividend Yield (0.032) settles around the average of (0.274) among similar stocks. P/S Ratio (1.981) is also within normal values, averaging (15.906).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BEN | IVZ | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 80 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 55 | |
SMR RATING 1..100 | 80 | 92 | |
PRICE GROWTH RATING 1..100 | 41 | 57 | |
P/E GROWTH RATING 1..100 | 50 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IVZ's Valuation (75) in the Investment Managers industry is in the same range as BEN (80). This means that IVZ’s stock grew similarly to BEN’s over the last 12 months.
IVZ's Profit vs Risk Rating (55) in the Investment Managers industry is in the same range as BEN (62). This means that IVZ’s stock grew similarly to BEN’s over the last 12 months.
BEN's SMR Rating (80) in the Investment Managers industry is in the same range as IVZ (92). This means that BEN’s stock grew similarly to IVZ’s over the last 12 months.
BEN's Price Growth Rating (41) in the Investment Managers industry is in the same range as IVZ (57). This means that BEN’s stock grew similarly to IVZ’s over the last 12 months.
BEN's P/E Growth Rating (50) in the Investment Managers industry is somewhat better than the same rating for IVZ (100). This means that BEN’s stock grew somewhat faster than IVZ’s over the last 12 months.
| BEN | IVZ | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 69% | 6 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 70% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 65% | 2 days ago 69% |
| Advances ODDS (%) | 11 days ago 63% | 18 days ago 68% |
| Declines ODDS (%) | 2 days ago 70% | 2 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 72% | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 59% | 2 days ago 60% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BEN’s FA Score shows that 0 FA rating(s) are green while IVZ’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BEN’s TA Score shows that 3 TA indicator(s) are bullish while IVZ’s TA Score has 3 bullish TA indicator(s).
BEN (@Investment Managers) experienced а -11.05% price change this week, while IVZ (@Investment Managers) price change was -8.33% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -8.27%. For the same industry, the average monthly price growth was -9.09%, and the average quarterly price growth was -10.90%.
BEN is expected to report earnings on Feb 01, 2027.
IVZ is expected to report earnings on Jan 26, 2027.
Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
A.I.dvisor indicates that over the last year, BEN has been loosely correlated with IVZ. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if BEN jumps, then IVZ could also see price increases.
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BLK. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BLK could also see price increases.